Program Goals

Interstitial lung diseases (ILDs) are difficult to diagnose, requiring advanced imaging by high-resolution computed tomography (HRCT), a detailed history and physical exam directed towards hundreds of possible risk factors and comorbidities, and often, multidisciplinary support. These life-threatening diseases challenge clinicians with variable presentations, numerous treatment options, and unpredictable outcomes. ILD patients suffer from common misdiagnosis and frequent under-treatment, and are often referred for lung transplantation evaluation too late.

This activity will inform physicians and advanced practice providers about the rapidly-advancing field, which encompasses many elements important to the care of an ILD patient, including accurate diagnosis, complications and comorbidities, treatment options, research opportunities, and transplantation evaluation.

Target Audience

This activity is intended for the following medical professionals who have a clinical interest in Interstitial Lung Diseases: Pulmonologists; Critical Care Specialists; Internal Medicine and Primary Care Physicians; Physician Assistants; Advanced Practice Nurses; and Nurse Practitioners.

Learning Objectives

After completion of this activity, participants should be able to:

1. Describe the importance of ILD diagnosis to outcomes and therapeutic options.
2. Review high-risk comorbidities and discuss risk factors for acute exacerbations.
3. Explain novel biomarkers available to every clinician.
4. Summarize treatment options for patients with inflammatory or autoimmune ILD causes, review indications for transplant referral, and describe areas of active investigation in clinical trials.

Faculty

Erin R. Camac, DO, FCCP
Associate Professor, Clinical Thoracic Medicine and Surgery
Associate Program Director, Internal Medicine Residency Program
Lewis Katz School of Medicine at Temple University
Temple University Hospital

Educational Activity Agenda

Front Matter & Registration (5 minutes)
Educational Presentation (34.20 minutes)
Post Test, Evaluation & Certificate delivery (15 minutes)
Total Activity: (54.20 minutes)

Release and Expiration Dates

Release Date: October 1, 2021
Expiration Date: October 1, 2023

Disclosure Policy

It is the policy of the Lewis Katz School of Medicine at Temple University, The Albert J. Finestone, M.D., Office for Continuing Medical Education that anyone in a position to control the content of a certified educational activity must disclose any financial relationships with ineligible companies within the prior 24 months. The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” Speakers must also disclose discussions of unlabeled/ unapproved uses of drugs or devices during their presentations. The Lewis Katz School of Medicine at Temple University has policies in place that will identify and mitigate all conflicts of interest prior to the educational activity. Detailed disclosure will be communicated to learners prior to the activity.

Faculty Disclosures

The faculty disclosed the following financial relationships with ineligible companies related to the content of this educational activity.

Erin R. Camac, DO, FCCP
• Nothing to Disclose

Course Directors, Planners, and Managers Disclosures

The course directors, planners, and managers disclosed the following financial relationships with ineligible companies related to the content of this educational activity:

Heather Greaves
• Nothing to disclose

Arnold I. Meyer, Ed.D, FACEHP
• Nothing to disclose

Katrina Ilagan
• Nothing to disclose

Roman V. Petrov, MD (Peer Review)
• Nothing to disclose

Accreditation Statement

Lewis Katz School of Medicine at Temple University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

Certification Statement

Lewis Katz School of Medicine at Temple University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Obtain CME Credit

Attendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit(s)™.  To receive credit, the course must be completed between October 1, 2021 - October 1, 2023.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive CME/CE credit for viewing the webcast:

• Read all of the CME/CE accreditation information above.
• View the complete electronic (web) activity.
• Click on the link to apply for CME/CE credits.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed, and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity.

Should you have any CME questions regarding this activity, please contact:

The Albert J. Finestone, MD Office for Continuing Medical Education
Lewis Katz School of Medicine at Temple University
3500 North Broad Street
11th Floor MERB
Philadelphia, PA 19140
Main CME Phone:  215-707-4787
Fax:  215-707-8268

System Requirements

To view this educational activity you, will need a web browser with JavaScript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work. 

If you have special accommodations that we can address to make your participation more meaningful and enjoyable, please contact our office at (215) 707-4787 or cme@temple.edu.